Dr. Steenkamp is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
732 Harrison Ave
Preston, 2nd Floor
Boston, MA 02118Phone+1 617-638-7470Fax+1 617-638-7449
Summary
- Devin Steenkamp is an endocrinologist with a particular interest in type 1 diabetes and atypical diabetes phenotypes such as monogenic diabetes. He is the Director of the Clinical Diabetes Program in the Section of Endocrinology, Diabetes and Nutrition at Boston Medical Center/Chobanian and Avedisian School of Medicine and his clinical practice and research interests are focused on the application of diabetes technologies in care
Education & Training
Boston University Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2011 - 2013
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2008 - 2011
University of Pretoria Faculty of MedicineClass of 2003
Certifications & Licensure
MA State Medical License 2011 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People With T2 Diabetes Start of enrollment: 2021 Apr 02
Roles: Contact
Publications & Presentations
PubMed
- 9 citationsMobile Health and Technology Usage by Patients in the Diabetes, Nutrition, and Weight Management Clinic at an Urban Academic Medical CenterMary-Catherine Stockman, Katherine L. Modzelewski, Devin Steenkamp
Diabetes Technology & Therapeutics. 2019-06-24 - 4 citationsMaking sense of glucose sensors in end-stage kidney disease: A review.Mark E Williams, Devin Steenkamp, Howard Wolpert
Frontiers in Clinical Diabetes and Healthcare. 2022-01-01 - 13 citationsAn amylin analog used as a challenge test for Alzheimer's disease.Haihao Zhu, Robert S. Stern, Qiushan Tao, Alexandra P. Bourlas, Maritza D. Essis
Alzheimer's & Dementia. 2017-01-01
Press Mentions
Navigating Type 2 Diabetes and Cardiovascular Disease: Insights from Dr. Devin SteenkampNovember 15th, 2024
How Community Health Workers Act as A ‘Bridge’ for Patients Needing Extra HelpFebruary 17th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
